Pitcairn CO Bio Rad Laboratories, Inc. Transaction History

Pitcairn CO

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$524.57 - $735.42 $272,776 - $382,418	-520 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$708.84 - $794.68 $85,769 - $96,156	-121 Reduced 18.88%	520 $393,000
Q3 2021 Nov 10, 2021	SELL	$657.71 - $825.77 $299,258 - $375,725	-455 Reduced 41.51%	641 $478,000
Q2 2021 Aug 11, 2021	SELL	$576.64 - $649.04 $425,560 - $478,991	-738 Reduced 40.24%	1,096 $706,000
Q1 2021 May 10, 2021	BUY	$547.01 - $662.35 $87,521 - $105,976	160 Added 9.56%	1,834 $1.05 Million
Q4 2020 Feb 05, 2021	BUY	$510.68 - $643.45 $77,112 - $97,160	151 Added 9.91%	1,674 $976,000
Q3 2020 Nov 03, 2020	BUY	$454.43 - $535.6 $488,966 - $576,305	1,076 Added 240.72%	1,523 $785,000
Q2 2020 Jul 28, 2020	BUY	$334.87 - $493.06 $149,686 - $220,397	447 New	447 $202,000

461

19.6M

23.2K

37.4K

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $8.17B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

Get notified when there are updates to the investment portfolio of Pitcairn CO, based on Form 13F filings with the SEC.

Stay updated on Pitcairn CO with notifications on news.